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Abstract
Several ethical issues exist within the diagnostic medical laboratory. The 
major ethical challenges such as; consent, confidentiality, codes of conduct, 
conflict of interest, lab utilisation, proficiency, and direct access testing are some 
times more prevalent in resource-limited settings. Presently, decisions regarding 
diagnosis and patient’s treatment are commonly taken on the basis of outcomes 
and interpretations of laboratory test results. Therefore, ethics plays a significant 
role in laboratory medicine. Apart from the lab results, laboratory staff is another 
important aspect of the laboratory. Hence, it is highly recommended that knowl-
edge of ethics helps to protect confidence; operational integrity, capability, 
impartiality, and safety of the staff. Many countries and their professional societ-
ies have developed policies and guidance material with regard to ethical issues 
in the area of laboratory medicine. The organizations specially; International 
of federation of clinical chemistry (IFCC), American Association of Clinical 
Chemistry (AACC) and International Organization for Standardization (ISO) 
have defined ethical recommendations for clinical laboratories. They are, in gen-
eral, outlined the responsibilities of laboratory professionals towards their pro-
fession, the patient, and the society. However, implication of ethical standards 
and guidelines are vary between different cultures, geographies, and according to 
available resources. In this chapter, we have mentioned the ethical consideration 
of IFCC, AACC and ISO 15189:2012 with regard to laboratory medicine and also 
addressed the various ethical issues that arises day to day in laboratory medicine 
in the current scenario.
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1. Introduction
In the current time, ethical concerns exist everywhere whether it is a medi-
cal field or life science. Lab Medicine and biomedical research, both fields are 
interconnected by laboratory testing where new results, remaining patient’s 
blood sample, and genetic testing, etc. are some of the major ethical issues that 
commonly exist. Ethical issues plays very crucial role in laboratory medicine. 
Therefore, it is required for laboratories to strictly follow ethical principles.  
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The field of ethics involves ‘a set of principles of right conduct’ [1] and bio-
ethics is well-defined as a branch of applied ethics that studies the philosophical, 
social and legal issues arising in medicine and life sciences. IFCC-task force 
has suggested that all the area of medicine to fulfill with ethical standards and 
guidelines and the field of lab medicine is no exemption. According to the IFCC 
verdict, prognosis as well as medications associated with certain medical condi-
tions is usually determined by outcome, results and analysis of laboratory tests 
[2]. When we talk about the laboratory system, staff comes at first as they are 
directly linked in interaction with patients and their care. Apart from laboratory 
staff, everyone who is involved on the way is equally responsible for maintaining 
laboratory ethical values. Henceforth, it is highly obligatory to evade any such 
activity that would downgrade the expertise, neutrality, outcomes, operational 
truthfulness or patient’s confidence in laboratory. Laboratory staff ’s behavior 
and etiquettes also comes in this category, thus, their actions should be in a 
professional way for example, wearing laboratory coat/apron, proper dressed-
up, phones should be turned silent/OFF during the time of testing and not 
discussing any report with clients and others. Hence, various international and 
national guidelines and declarations have been evolved with time to time and 
thus critically upgraded the practice of bio-ethics in the field of biomedical 
research. Compliance with these guidelines confirms the autonomy, dignity and 
well-being of participants as well as the integrity and credibility of research 
results [3].
2. Evolution of ethics
Evolution of biologically-centered ethical guidelines in medical or biomedical 
research has upgraded the understanding of ethics over the years. Various guide-
lines and declarations evolved over the period, including international and national, 
are mentioned as below:
2.1 International guidelines
a. Nuremberg Code, 1947: This code was the initiation of modern ethical morals. 
It introduced the discussion on rationale and explanation of research risks or 
benefits analysis. Initially there was no ethical conduct for the research involv-
ing biological subjects, the time before World War II. Nuremberg, during 1947, 
was the first to establish ethical principles for such researches which delineates 
the necessity of competent and trained staff, participant’s consent, and circum-
stances under which research should be discontinued [4].
b. Declaration of Geneva, 1948: It comes into existence soon after Nuremberg 
code which emphasized guidelines for ethical issues related to clinical medi-
cine. Soon after Nuremberg code, Declaration of Geneva was conscripted and 
accepted by World Medical Association (WMA) in 1948. It was actually a phy-
sician’s oath that was proposed as an amendment of Hippocratic Oath which 
was the assertion of physician’s commitment towards his duty for humanity 
in medicine. Its concept is applicable to clinical medicine unlike Nuremberg 
code [5].
c. Declaration of Helsinki, 1964, Revised 1983, 1989, 1996, 2000, 2008, 
2013: It is obliged to make individual rights as informed decisions, duties of 
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investigators and research participant’s welfare as well. It was developed by 
World Medical Association (WMA) which includes the set of ethical morali-
ties for conducting research involving humans for medical community. Ten 
principles of Nuremberg code and Declaration of Geneva were tied in a single 
document named as ‘Declaration of Helsinki’ [6].
d. Belmont report, 1978–1979: The Belmont Report was generated by the United 
States of America (USA) National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research in 1978. It is one of the key 
work concerning ethics and healthcare research and explains the ethical guide-
lines for experiments involving human participants. It three basic principles 
includes the respect for participants, justice and beneficence. In research these 
basic principles obliged to consider. It also saves the rights of participants in 
clinical and experimental researches. It also describes the approval of study by 
the Institutional ethical committee and ensures that participant should at least 
get nominal care for their medical condition [7].
e. CIOMS guidelines [Council for International organizations of Medical 
Sciences], 1992–1993, Revised 2002: International ethical guidelines were 
announced by CIOMS for epidemiological studies in 1991 and for researches 
involving human participants were announced in 1993. It focusses on the 
pharmacovigilance, reporting of adverse drug effects along with protection of 
research participants [8].
2.2 National guidelines
a. National ethical guidelines for Health Research and biomedical sciences 
involving Human Contributors; ICMR, 2017.
In 2017, Indian Council of Medical Research introduced ethical guidelines for 
research on Human Participants. In India, it is mandatory for all research organiza-
tions to strictly follow these guidelines in letter for all types of biomedical research 
involving human beings, along with complete documentation to protect safety and 
wellbeing of all participants [9].
3. Principles of ethics
The important three core ethical principles are discussed in all documents. These 
are as below (Figure 1):
a. Respect for persons: We must respect patient and their self-respect. There 
is freedom of decisions to the each participant of the study. It is an obliga-
tion to respect the decisions made by people concerning their own lives. 
This is respecting human dignity. We must not interfere with the decisions 
of competent adults, and also actively empower others for whom we are 
responsible.
b. Beneficence: It refers to our duties in the best interests of the patients or 
research participants. The goal is to maximize benefits and minimize harms, 
the latter sometimes Latinate as non-maleficence. Everyone must be fair and 
correct in all their actions and must take positive steps to prevent harm.
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c. Justice: It is an obligation to provide all participants with whatever they are 
deserve. Basically, we have an obligation to treat all people equally, fairly, 
and impartially. All individuals should have an opportunity to participate in 
research unless contraindicated and we must not impose unfair burdens. All 
doubts of research participants should be cleared by concerned staff. We should 
make available all the safety concerns as demanded by research participants.
4. Various international ethical considerations
Similar to other fields of medicine, laboratory medicine is obliged to adhere 
to high ethical standards. With the advancement of medical science in the area of 
laboratory medicine, special ethical considerations should be taken in addition to 
the general ethical framework followed in biomedical research. Various policies 
and guidelines related to ethical issues are being developed time to time by several 
countries or related societies.
4.1 Ethical consideration in ISO 15189
The International Organization for Standardization (ISO) that created ISO 
15189:2012 “Medical laboratories-Requirements for quality and competence” in 2012 
[10]. Its section 4.1.1.3 elaborated the ethical conduct required in laboratories. ISO 
15189 is technically applicable for laboratory equipment, personnel, environmental 
conditions, consumables, pre- and post-examination processes, reporting and 
release of laboratory results, and lab information management. As per ISO 15189 
standards, the core principles that stated in documents are: (i) there should not be 
participation in any activities that would diminish confidence in the laboratory’s 
competence, impartiality, judgment or operational integrity; (ii) management and 
personnel are free from any undue commercial, financial, or others pressure and 
influences that may adversely affect the quality of work; (iii) where potential con-
flicts in competing interests exist, they shall be openly and appropriately declared; 
(iv) there are appropriate procedures to ensure that staff treat human samples, 
tissues or remains according to relevant legal requirements; (v) confidentiality of 
information is maintained.
Figure 1. 
Core principles of ethics.
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4.2 Ethical consideration in AACC
The American Association for Clinical Chemistry (AACC) has also recommended 
fifteen principles of ethical conduct for laboratories. The major highlights are that 
[11]: (i) to be honest in all professional accomplishments, and retain the high level 
of personal veracity; (ii) need to avoid any scientific or professional delinquency; 
(iii) should report any professional that is degrading the standards of laboratory and 
professionalism that would affect patients care; (iv) to maintain high quality reagents, 
equipments and consumables. Also, they must confirm the reliability of test reports 
and quality of confidentiality of reports; (v) respect the privacy and confidentiality of 
protected health information; (vi) continuously endeavor to augment the professional 
qualifications, knowledge, and skills, and present them accurately; (vii) encourages 
the safety of patients, staff and the environment; (viii) must disclose the actual 
conflicts of interests; (ix) encourage open and honest discussion among physicians, 
other healthcare providers and/or facility managers; (x) fulfill the appropriate laws 
and pursue to change whenever they seem contrary to patient’s interests.
4.3 Ethical consideration in IFCC
Despite the importance of bio-ethics in lab medicine, still there are lacunae in 
education training focused on ethics in laboratory. To address this issue, IFCC has 
recently constituted a task force on ethics (TF-E) to rationalize the documents and 
spread the education and training on ethics [12]. This task force (TF-E) has created 
a toolkit which serves as a repository of documents developed worldwide in the 
kingdom of laboratory ethics [13]. Although the members of the IFCC Task Force 
on Ethics also contribute to achieve the goal of ethics education in the field of labo-
ratory medicine through the publications on the topic of ethics in collaboration with 
the electronic journal of International Federation of Clinical Chemistry (eJIFCC).
5. Codes of ethics
Professional personnel of a medical laboratory are bound by the ethical codes of 
their respective profession. A code of ethics may be described as an expression of 
basic values –the principles and standards by which we should conduct ourselves. 
Several laboratory professional societies and organizations have developed codes of 
ethics, with common principles of conduct which act as guidelines to professional 
members of those organizations [14]. The International Federation of Biomedical 
Laboratory Science (IFBLS) suggests to maintain strict confidentiality of patient 
information and test results; safeguard the dignity and privacy of patients and 
above all be accountable for the quality and integrity of clinical laboratory services 
being provided [15]. In same line, the American Society of Clinical Pathologists 
(ASCP) has also advised laboratory staff to treat patients and colleagues with 
respect, care and thoughtfulness; perform duties in an accurate, precise, timely and 
responsible manner; and safeguard patient information as confidential, within the 
limits of the law.
6. Ethical issues in laboratory
There are several ethical issues in laboratory (Figure 2). These issues 
have divided into three phases according to the laboratory work distribution. 
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Pre-analytical phase issues are related to patient’s interaction, specimen collection, 
sample receiving and its transport. Analytical phase issues are usually related to 
quality control, whereas, post-analytical phase issues are related to reporting of 
results, keeping and maintaining records [16].
6.1 Pre-analytical phase
Clinicians ordering laboratory tests is also comes under the most important 
ethical obligations. The laboratory personnel are required to act every time to 
confirm whether the tests, which are referred by a clinician, are being met with 
the diseased person requesting the tests or not. However, it is commonly assumed 
that clinicians are referring laboratory tests so as to benefit the patient without any 
financial interests. In this phase, there is collective responsibility of many people 
including nurse, healthcare providers, researcher, or the technical staff collecting 
the samples. Their role includes:
1. Identification of a patient with respect to the tests ordered.
2. Proper collection, labelling, and handling of samples till the tests are 
performed.
Three basic ethical principles in pre-analytical phase are:
a. Respect for persons: Consent must be understood by the patient. It may be 
expressed if a participant is asked for written agreement. It may be implied 
Figure 2. 
Ethical issues in laboratory phases.
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when patient is comfortably sits and allows his sample to be taken. Informed 
consent may lead to an ethical problem if participant is incompetent owing to 
age, mental status, or critical illness. The patient’s right to refuse to get tests 
done should be appreciated. In special cases, healthcare professionals should 
be obliged to consult the institutional guidelines. Any information regard-
ing patient’s demographics, their visit to the testing laboratory, the tests that 
were ordered, and the requirement for these tests, should be provided only to 
suitable personnel. At every step of sample handling, from sample collection to 
data entry, confidentiality should be maintained.
b. Beneficence: All tests performed/referred must benefit to patient. Any adverse 
event during or after sample collection have to be managed by trained workers, 
with the help of standard operating procedures (SOPs). Collection of samples 
should be done as per universally recommended precautions so as to protect 
the patient and the healthcare worker. The additional samples should not be 
drawn from the patient without informing and getting the permission from 
Institutional ethics committee. The specimens should be well-labeled with 
minimum two unique identifiers. Transportation of samples should be done to 
protect the integrity of the sample.
c. Justice: It provides access to several laboratory tests at reasonable cost. The 
laboratory should evaluate the need to introduce new tests and the opportuni-
ties to discontinue older tests when better tests are available. No preference 
should be given to some patients in order to facilitate or accelerate the collection 
procedure at the cost of others.
6.2 Analytical phase
In laboratories settings confidentiality, quality and competency are essential. 
During this, confidentiality is almost a by-product of laboratory automation which 
uses automated code readers, automated analysis, as well as auto-verification and 
also names of patients are normally given a unique sequential number for process-
ing. Maintaining confidentiality is more challenging during the analytical phase 
in small laboratories as compared to larger ones, as smaller laboratories perform 
manual testing. However, it is most important to maintain ethical standards by 
each laboratory in conducting patient’s testing. The three principles in this phase 
are as follows:
a. Respect for persons: After collection and processing of samples, patients 
have the right to refuse to have their specimens examined. In such a case, 
confidentially should be appreciated and preserved. Special care must be 
taken to preserve confidentiality in point-of-care testing as much as possible.
b. Beneficence: The aim of the laboratory is to make available the best possible 
result to patient. This is accomplished via good laboratory practices (GLP) 
and maintaining high professional standards. Good laboratory practice should 
involve the establishment of demanding quality assurance program including 
quality control analysis, proficiency testing and accreditation of laboratory. In 
this regard “a wrong result is worse than no result” is a critical guiding princi-
ple. Good laboratory practice (GLP) refuses to evaluate or account a result in 
the presence of poor sample integrity, improper or poor labeling or any other 
insufficiency that may lead to compromise with the test result. In this regard, 
Acceptability of “difficult to obtain” (such as cerebrospinal fluid) samples 
may be taken as special case, and departmental facilities should develop some 
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suitable policy on examination and records of such specimens where specimen 
integrity or identification is being compromised. All laboratories should main-
tain proper authorization as required by their country or region. Only qualified, 
properly skilled and regularly re-accredited employees should be authorized to 
execute point-of-care testing (POCT).
c. Justice: There should be no discrimination in the examination of patient’s 
samples on the basis of gender, age or race; otherwise it would be an injustice. 
All samples should be treated likewise. It is recognized, that laboratories must 
develop some appropriate provision for STAT or priority testing. Laboratories 
should also state which tests are included and their expected turnaround times. 
It is anticipated that all specimens are being analyzed correctly in a timely 
routine.
6.3 Post analytical phase
This phase includes reporting and interpretation of tests results, storage of 
residual sample, and access to the data. All laboratories should have a procedure for 
storage of a specimen that is analyte dependent. An essential part of good labora-
tory practice is to archive the results either in electronic and/or hard copy format. 
Documents that can be archived include request forms, raw analytical as well as 
quality control data, results, and reports. Guidelines on retention or destruction of 
medical records along with remaining sample retention and its dispose of should be 
kept in place. Policy manual should also mention the strategies on the identification 
of authorized personnel such as doctors, patients, and laboratory staff; that would 
be allowed to access medical records. Besides this, the patient should have the right 
to give consent to access by others (such as family members), if required. Applying 
the basic ethical principles in post analytical phase as follows:
a. Respect for persons: Patients reasonably expect that their specimens will not 
be used beyond the testing prescribed by a clinician and solely used for only 
prescribed testing for medical purposes. However, in the world substantial dif-
ferences are there concerning the confidentiality of results. In many areas, the 
patient and referring clinician are the only authentic recipients of laboratory 
data. Exceptions are there in case if patients are not able to receive or under-
stand the tests reports. In other areas, the patient’s family is also considered 
to be genuine recipients of a patient’s test reports. Laboratories must develop 
a strategy for results dissemination so as to respect local customs. Reliable 
communication methods are to be used, and security should be protected in 
conveying the results regardless of the channel of communications including, 
hand deliveries by messengers. The local ethics committee or board should 
also have provision on any further testing in residual specimen (except for the 
samples used in validation processes), and patient consent may be obligatory.
b. Beneficence: Results misinterpretation may harm the patients and it could 
be reduced only when a skilled staff would interpret the reports; to minimize 
this harm. The reporting should be in proper time with correct and all neces-
sary information so that clinician gets the true interpretation. Furthermore, a 
complete report usually covers the name of the test executed, a suitable refer-
ence interval (which might be age or gender specific), units of measurement 
if needed, and a remarking that the result is within or outside the reference 
interval. As per laboratory conditions, turnaround time (TAT) should be 
minimum for any test but it should not compromise the legitimacy of the 
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results. Timely access to test results is very essential for the welfare of patients, 
particularly in emergency conditions and delaying the access to results in case 
of non-payment may harm the patient and ethically also not correct. Hence, 
delaying in reporting should be avoided. Errors should be notified to clinicians 
immediately after they came into notice and test results should be rectified 
or repeat tests should be done, whichever required. Finally, incorrect results 
should be still accessible but marked as erroneous and corrected result should 
be mentioned on the report.
c. Justice: Although reporting of test results must be consistent for all patients, 
speedy reporting may possibly be demanded for some results, including “critical” 
and “significant-risk” results. Instructions for quick reporting must apply irre-
spective of the source of sample as well as the patient’s financial capability and 
not disclosing the results just due to payment should also be avoided. Remaining 
patient’s samples should not be used further without patient’s knowledge which 
is very common these days. There is much discussion in the literature about who 
owns patient specimens and whether patients should share in profits if financial 
gains are derived from leftover samples. However, rules and practices differ 
among different regions and institutions.
7. Conclusion
Finally, it has been observed that it is necessary to incorporate the core principles 
and guidelines of bioethics in the areas of laboratory medicine. Any laboratory 
involving human participants should follow international standards and practices 
of ethics. Laboratories shall not engage in practices restricted by law and should 
uphold the reputation of their profession. It is required to develop an ethics policy 
and add it to the laboratory’s quality assurance manual. Development and imple-
mentation of an ethics training program for laboratory staff should be done in such 
a way that it would promote the development of the professional life of laboratory 
staff, highlighting human values and responsibility, honesty in their work. This will 
surely initiates and encourages the change of paradigm with the aim of increasing 
knowledge keeping in mind ethical principles in daily procedures.
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